The introduction of Anthralin into lysated human prostate adenocarcinoma cells caused a 50–70% reduction in the general proteolytic activity, which attests to the fact that anthralin has an efficient inhibiting action on native hepsin localized on the membranes of tumor cells. This evidence concerns the gene HPN and prostate adenocarcinoma.